That's like saying oh, well flight 149 crashed, no one else should fly for a year- I ceased to e amazed at the level of shot that flies through these grapevines at times.
The write up is even funnier because AXIM doesn't have just one clinical trial, they have about 3 now- which narrows chances of full failure- ppl are sheep to believe such crap-
It was awkwardly written, but that PR was written by Emerging Growth Corp, which AXIM hired to promote the company and stock. Scroll down the disclaimer to the list of clients:
They also promote Isodiol (which supplies the CBD) and MJNA, AXIM's main investor.
The author was trying to make the point that AXIM addresses all the shortcomings of a company like ZYNE, but took so long to get to the point, that I doubt that few people read beyond the first couple of paragraphs.